Burns, Sarah S.Kapur, Reuben2021-03-292021-03-292020-08-11Burns, S. S., & Kapur, R. (2020). Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential. Stem Cell Reports, 15(2), 292–306. https://doi.org/10.1016/j.stemcr.2020.06.0212213-6711https://hdl.handle.net/1805/25477Characterized by the expansion of somatic mutations in the hematopoietic lineages of aging individuals, clonal hematopoiesis of indeterminate potential (CHIP) is a common condition that increases the risk of developing hematological malignancies and cardiovascular disease (CVD). The presence of CHIP-associated mutations in hematopoietic stem and progenitor cells (HSPCs) suggests that these mutations may alter the functions of the diverse hematopoietic lineages, many of which influence the pathogenesis of CVD. Inflammation may be a potential pathogenic mechanism, linking both CVD and hematological malignancy. However, it remains unknown whether CHIP-associated CVD and hematological malignancy are features of a common disease spectrum. The contributions of CHIP-associated mutations to both CVD and hematological malignancy underscore the importance of stem cell biology in pathogenesis and treatment. This review discusses possible mechanisms underlying the contributions of multiple hematopoietic lineages to CHIP-associated CVD and the putative pathogenic links between CHIP-associated CVD and hematological malignancy.en-USAttribution-NonCommercial-NoDerivatives 4.0 Internationalhematopoietic stem and progenitor cellscardiovascular diseaseclonal hematopoiesis of indeterminate potentialhematological malignancyinflammationArticle